Biocartis Group NV
XBRU:BCART

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
XBRU:BCART
Watchlist
Price: 0.29 EUR Market Closed
Market Cap: 27.2m EUR
Have any thoughts about
Biocartis Group NV?
Write Note

Biocartis Group NV
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biocartis Group NV
Cost of Revenue Peer Comparison

Comparables:
NYXH
IBAB
SEQUA

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biocartis Group NV
XBRU:BCART
Cost of Revenue
-€29.5m
CAGR 3-Years
-11%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Nyxoah SA
XBRU:NYXH
Cost of Revenue
-€1.7m
CAGR 3-Years
-281%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ion Beam Applications SA
XBRU:IBAB
Cost of Revenue
-€294.3m
CAGR 3-Years
-19%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Sequana Medical NV
XBRU:SEQUA
Cost of Revenue
-€4.1m
CAGR 3-Years
-26%
CAGR 5-Years
-27%
CAGR 10-Years
N/A

See Also

What is Biocartis Group NV's Cost of Revenue?
Cost of Revenue
-29.5m EUR

Based on the financial report for Jun 30, 2023, Biocartis Group NV's Cost of Revenue amounts to -29.5m EUR.

What is Biocartis Group NV's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-19%

Over the last year, the Cost of Revenue growth was 4%. The average annual Cost of Revenue growth rates for Biocartis Group NV have been -11% over the past three years , -19% over the past five years .

Back to Top